A mechanism of Rap1-induced stabilization of endothelial cell-cell junctions

Molecular Biology of the Cell

Volumn 22, Issue 14, 2011, Pages 2509-2519

  Liu, Jian J ^a   Stockton, Rebecca A ^a   Gingras, Alexandre R ^b   Ablooglu, Ararat J ^a   Han, Jaewon ^a   Bobkov, Andrey A ^c   Ginsberg, Mark H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BINDING PROTEIN; KREV INTERACTION TRAPPED PROTEIN 1; MUTANT PROTEIN; RAP1 PROTEIN; RHO KINASE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CARDIOVASCULAR DEVELOPMENT; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MICROTUBULE; MOLECULAR MODEL; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY;

ANIMALS; CARDIOVASCULAR SYSTEM; ENDOTHELIAL CELLS; GENE EXPRESSION; GENETIC VECTORS; HEK293 CELLS; HUMANS; INTERCELLULAR JUNCTIONS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MUSCLE PROTEINS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; RAP1 GTP-BINDING PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; UMBILICAL VEINS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 79960309920     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-02-0157     Document Type: Article

References (43)

1. Benkert P, Kunzli M, Schwede T (2009). QMEAN server for protein model quality estimation. Nucleic Acids Res 37, W510-W514.
2. Beraud-Dufour S, Gautier R, Albiges-Rizo C, Chardin P, Faurobert E (2007). Krit 1 interactions with microtubules and membranes are regulated by Rap1 and integrin cytoplasmic domain associated protein-1. FEBS J 274, 5518-5532. (Pubitemid 47622064)
3. Bos JL (2005). Linking Rap to cell adhesion. Curr Opin Cell Biol 17, 123-128.
4. Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, Mayadas TN (2005). Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 105, 1950-1955. (Pubitemid 40731777)
5. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010). Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66, 486-501.
6. Francalanci F et al. (2009). Structural and functional differences between KRIT1A and KRIT1B isoforms: a framework for understanding CCM pathogenesis. Exp Cell Res 315, 285-303.
7. Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y, Kangawa K, Mochizuki N (2005). Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 25, 136-146. (Pubitemid 40039806)
8. Glading A, Han J, Stockton RA, Ginsberg MH (2007). KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell-cell junctions. J Cell Biol 179, 247-254. (Pubitemid 350004889)
9. Glading AJ, Ginsberg MH (2010). Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling. Dis Model Mech 3, 73-83.
10. Gorzalczany Y, Sigal N, Itan M, Lotan O, Pick E (2000). Targeting of Rac1 to the phagocyte membrane is sufficient for the induction of NADPH oxidase assembly. J Biol Chem 275, 40073-40081. (Pubitemid 32064632)
11. Guex N, Peitsch MC (1997). SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18, 2714-2723. (Pubitemid 28059943)
12. Gunel M, Laurans MS, Shin D, DiLuna ML, Voorhees J, Choate K, Nelson-Williams C, Lifton RP (2002). KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein. Proc Natl Acad Sci USA 99, 10677-10682.
13. Han J et al. (2006). Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr Biol 16, 1796-1806. (Pubitemid 44354146)
14. Herrmann C, Nassar N (1996). Ras and its effectors. Prog Biophys Mol Biol 66, 1-41. (Pubitemid 27161004)
15. Hogan C, Serpente N, Cogram P, Hosking CR, Bialucha CU, Feller SM, Braga VM, Birchmeier W, Fujita Y (2004). Rap1 regulates the formation of E-cadherin-based cell-cell contacts. Mol Cell Biol 24, 6690-6700. (Pubitemid 38944348)
16. Kinbara K, Goldfinger LE, Hansen M, Chou FL, Ginsberg MH (2003). Ras GTPases: integrins' friends or foes? Nat Rev Mol Cell Biol 4, 767-776.
17. Kleaveland B et al. (2009). Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat Med 15, 169-176.
18. Kooistra MR, Corada M, Dejana E, Bos JL (2005). Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 579, 4966-4972. (Pubitemid 41242837)
19. Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, Marechal E, Joutel A, Bach JF, Tournier-Lasserve E (1999). Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23, 189-193. (Pubitemid 29455391)
20. Lim CJ, Han J, Yousefi N, Ma Y, Amieux PS, McKnight GS, Taylor SS, Ginsberg MH (2007). Alpha4 integrins are type I cAMP-dependent protein kinase-anchoring proteins. Nat Cell Biol 9, 415-421. (Pubitemid 46511074)
21. Mably JD, Chuang LP, Serluca FC, Mohideen MA, Chen JN, Fishman MC (2006). santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development 133, 3139-3146. (Pubitemid 44404337)
22. Nassar N, Horn G, Herrmann C, Scherer A, McCormick F, Wittinghofer A (1995). The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature 375, 554-560.
23. Pfaff M, Liu S, Erle DJ, Ginsberg MH (1998). Integrin beta cytoplasmic domains differentially bind to cytoskeletal proteins. J Biol Chem 273, 6104-6109. (Pubitemid 28144690)
24. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K (2005). Scalable molecular dynamics with NAMD. J Comput Chem 26, 1781-1802. (Pubitemid 43078511)
25. Raaijmakers JH, Bos JL (2009). Specificity in Ras and Rap signaling. J Biol Chem 284, 10995-10999.
26. Roy A, Kucukural A, Zhang Y (2010). I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5, 725-738.
27. Sahoo T et al. (1999). Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 8, 2325-2333. (Pubitemid 29525349)
28. Sahoo T et al. (2001). Computational and experimental analyses reveal previously undetected coding exons of the KRIT1 (CCM1) gene. Genomics 71, 123-126. (Pubitemid 32097210)
29. Sakurai A, Fukuhara S, Yamagishi A, Sako K, Kamioka Y, Masuda M, Nakaoka Y, Mochizuki N (2006). MAGI-1 is required for Rap1 activation upon cell-cell contact and for enhancement of vascular endothelial cadherin-mediated cell adhesion. Mol Biol Cell 17, 966-976. (Pubitemid 43191128)
30. Serebriiskii I, Estojak J, Sonoda G, Testa JR, Golemis EA (1997). Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 15, 1043-1049. (Pubitemid 27401958)
31. Spaargaren M, Bischoff JR (1994). Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. Proc Natl Acad Sci USA 91, 12609-12613.
32. Stockton RA, Shenkar R, Awad IA, Ginsberg MH (2010). Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 207, 881-896.
33. Tozer GM, Kanthou C, Baguley BC (2005). Disrupting tumour blood vessels. Nat Rev Cancer 5, 423-435. (Pubitemid 40791485)
34. Tucker J, Sczakiel G, Feuerstein J, John J, Goody RS, Wittinghofer A (1986). Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide-binding site. EMBO J 5, 1351-1358.
35. Verin AD, Birukova A, Wang P, Liu F, Becker P, Birukov K, Garcia JG (2001). Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation. Am J Physiol Lung Cell Mol Physiol 281, L565-L574.
36. Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY (2004). Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 131, 1437-1448. (Pubitemid 38443895)
37. Wittchen ES, van Buul JD, Burridge K, Worthylake RA (2005). Trading spaces: Rap, Rac, and Rho as architects of transendothelial migration. Curr Opin Hematol 12, 14-21. (Pubitemid 40189234)
38. Zawistowski JS, Serebriiskii IG, Lee MF, Golemis EA, Marchuk DA (2002). KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum Mol Genet 11, 389-396. (Pubitemid 34213612)
39. Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson GL, Marchuk DA (2005). CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet 14, 2521-2531. (Pubitemid 41236065)
40. Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC (2001). Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10, 2953-2960. (Pubitemid 34030926)
41. Zhang J, Rigamonti D, Dietz HC, Clatterbuck RE (2007). Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations. Neurosurgery 60, 353-359, discussion 359.
42. Zhang Y (2008). I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9, 40.
43. Zhang Y (2009). I-TASSER: fully automated protein structure prediction in CASP8. Proteins 77, Suppl 9, 100-113.